DE69942314D1 - Versuchsanordnung zum nachweis von bindungspartnern - Google Patents

Versuchsanordnung zum nachweis von bindungspartnern

Info

Publication number
DE69942314D1
DE69942314D1 DE69942314T DE69942314T DE69942314D1 DE 69942314 D1 DE69942314 D1 DE 69942314D1 DE 69942314 T DE69942314 T DE 69942314T DE 69942314 T DE69942314 T DE 69942314T DE 69942314 D1 DE69942314 D1 DE 69942314D1
Authority
DE
Germany
Prior art keywords
binding partners
detecting binding
trial assembly
leukemia
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69942314T
Other languages
English (en)
Inventor
Richard Ian Christopherson
Remedios Cristobal G Dos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medsaic Pty Ltd
Original Assignee
Medsaic Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP7916A external-priority patent/AUPP791698A0/en
Priority claimed from AUPQ0425A external-priority patent/AUPQ042599A0/en
Application filed by Medsaic Pty Ltd filed Critical Medsaic Pty Ltd
Application granted granted Critical
Publication of DE69942314D1 publication Critical patent/DE69942314D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Motorcycle And Bicycle Frame (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Basic Packing Technique (AREA)
DE69942314T 1998-12-23 1999-12-23 Versuchsanordnung zum nachweis von bindungspartnern Expired - Lifetime DE69942314D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP7916A AUPP791698A0 (en) 1998-12-23 1998-12-23 An assay
AUPQ0425A AUPQ042599A0 (en) 1999-05-18 1999-05-18 An assay-ii
PCT/AU1999/001156 WO2000039580A1 (en) 1998-12-23 1999-12-23 An assay to detect a binding partner

Publications (1)

Publication Number Publication Date
DE69942314D1 true DE69942314D1 (de) 2010-06-10

Family

ID=25645962

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69942314T Expired - Lifetime DE69942314D1 (de) 1998-12-23 1999-12-23 Versuchsanordnung zum nachweis von bindungspartnern

Country Status (15)

Country Link
US (1) US7560226B2 (de)
EP (1) EP1151300B1 (de)
JP (1) JP4763135B2 (de)
KR (1) KR100795757B1 (de)
CN (1) CN1231761C (de)
AT (1) ATE466280T1 (de)
BR (1) BR9916449A (de)
CA (1) CA2356286C (de)
DE (1) DE69942314D1 (de)
DK (1) DK1151300T3 (de)
ES (1) ES2344180T3 (de)
HK (1) HK1041922A1 (de)
NZ (1) NZ525421A (de)
PT (1) PT1151300E (de)
WO (1) WO2000039580A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU740830B2 (en) * 1998-01-29 2001-11-15 Glaucus Proteomics B.V. High density arrays for proteome analysis and methods and compositions therefor
AUPR005600A0 (en) * 2000-09-12 2000-10-05 University Of Sydney, The Diagnostic assay
AU3102802A (en) 2000-12-14 2002-06-24 Paul Stroobant Differential phage capture proteomics
EP1248108B1 (de) 2001-03-29 2011-08-31 Canon Kabushiki Kaisha Verfahren zum Zellscreening und dafür geeignete Substrata
CN100405062C (zh) * 2001-04-10 2008-07-23 利兰·斯坦福青年大学托管委员会 抗体特异性分布的治疗和诊断使用
CA2450814A1 (en) * 2001-07-02 2003-07-17 The Board Of Trustees Of The Leland Stanford Junior University Microarrays for cell phenotyping and manipulation
DE60233744D1 (de) 2001-09-20 2009-10-29 Univ Texas Bestimmung der zirkulierenden therapeutischen antikörper, antigene sowie antigen-antikörper-komplexe mit elisa-tests
WO2003075016A1 (en) 2002-03-07 2003-09-12 Cambridge University Technical Services Limited (Cuts) Scd fingerprints
WO2004001377A2 (en) * 2002-06-20 2003-12-31 Paul Stroobant Improved methods for performing differential capture proteomics
DE10236101A1 (de) * 2002-08-05 2004-02-26 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Verfahren und Kit zur Durchführung funktioneller Tests an biologischen Zellen
CA2518677A1 (en) * 2003-03-03 2004-12-09 Nagaoka & Co., Ltd. Methods and apparatus for use in detection and quantitation of various cell types and use of optical bio-disc for performing same
WO2004087865A2 (en) * 2003-03-31 2004-10-14 The Regents Of The University Of California The preparation and application of ligand-biopolymer conjugates
EP1611443A1 (de) * 2003-04-04 2006-01-04 Biacore AB Verfahren und kit für einen zellanalyt-assay
SE0301058D0 (sv) 2003-04-10 2003-04-10 Biacore Ab Method and kit for cell analyte assay
US8242254B2 (en) 2003-09-11 2012-08-14 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US20080138808A1 (en) * 2003-09-11 2008-06-12 Hall Thomas A Methods for identification of sepsis-causing bacteria
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8546082B2 (en) * 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US20050069958A1 (en) * 2003-09-26 2005-03-31 Mills Rhonda A. Method for simultaneous evaluation of a sample containing a cellular target and a soluble analyte
DE102004039628A1 (de) * 2004-08-10 2006-02-23 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Trägerplatte zur Durchführung funktioneller Tests an biologischen Zellen sowie Verfahren zur Beschichtung der Trägerplatte
CA2608092A1 (en) * 2005-05-18 2006-11-23 Wyeth Leukemia disease genes and uses thereof
WO2006132666A1 (en) * 2005-06-06 2006-12-14 Decision Biomarkers, Inc. Assays based on liquid flow over arrays
US20070042443A1 (en) * 2005-08-17 2007-02-22 Quest Diagnostics Investments Incorporated Hematopoietic cell phenotyping using free circulating cellular markers
JP5127718B2 (ja) * 2005-10-29 2013-01-23 バイエル・テクノロジー・サービシズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 複雑な組成を有する生物学的起源のサンプル中の１種若しくはそれ以上の被検体の測定方法およびその使用
US20070105165A1 (en) * 2005-11-04 2007-05-10 Charles Goolsby Composite profiles of cell antigens and target signal transduction proteins for analysis and clinical management of hematologic cancers
WO2007062466A1 (en) 2005-11-29 2007-06-07 The University Of Sydney Demibodies: dimerisation-activated therapeutic agents
US20070192884A1 (en) * 2006-01-25 2007-08-16 Daniel Chelsky TAT-038 and methods of assessing and treating cancer
CN101449162B (zh) 2006-05-18 2013-07-31 分子压型学会股份有限公司 确定针对病状的个性化医疗介入的系统和方法
US8768629B2 (en) * 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
WO2009108932A2 (en) * 2008-02-28 2009-09-03 The Johns Hopkins University Selectin ligands useful in the diagnosis and treatment of cancer
GB0818614D0 (en) * 2008-10-10 2008-11-19 Univ Dublin City Platelet Analysis
WO2010045318A2 (en) * 2008-10-14 2010-04-22 Caris Mpi, Inc. Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type
EP3181705A1 (de) * 2008-11-12 2017-06-21 Caris Life Sciences Switzerland Holdings GmbH Verfahren und systeme zur verwendung von exosomen zur bestimmung von phänotypen
JP5808349B2 (ja) 2010-03-01 2015-11-10 カリス ライフ サイエンシズ スウィッツァーランド ホールディングスゲーエムベーハー セラノーシスのためのバイオマーカー
US9469876B2 (en) 2010-04-06 2016-10-18 Caris Life Sciences Switzerland Holdings Gmbh Circulating biomarkers for metastatic prostate cancer
WO2012048372A1 (en) * 2010-10-11 2012-04-19 Medsaic Pty Ltd Assay for disease detection
EP2743701B1 (de) * 2011-08-12 2016-04-27 LSI Medience Corporation Verfahren zum nachweis von infektionen an stellen einer operation
CN103235124A (zh) * 2013-04-22 2013-08-07 复旦大学 一种基于硝酸纤维素膜的便捷癌细胞捕获芯片
WO2014205344A2 (en) * 2013-06-21 2014-12-24 The Johns Hopkins University Virion display array for profiling functions and interactions of human membrane proteins
JP2018502281A (ja) * 2014-11-20 2018-01-25 ジーイー・ヘルスケア・ユーケイ・リミテッド 固体支持体材料に固定された認知症及びアルツハイマー病関連バイオマーカーの検出
CN105005484B (zh) * 2015-08-12 2021-04-20 厦门雅基软件有限公司 一种跨平台游戏开发工具的事件分发方法
US20200206187A1 (en) * 2017-07-08 2020-07-02 Rudolph E. Tanzi Screening platform to identify therapeutic drugs or agents for treatment of alzheimer's disease

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA822896B (en) * 1981-04-29 1982-12-29 Ciba Geigy New devices and kits for immunological analysis
US4591570A (en) * 1983-02-02 1986-05-27 Centocor, Inc. Matrix of antibody-coated spots for determination of antigens
US4797356A (en) * 1985-12-02 1989-01-10 Konishiroku Photo Industries, Co., Ltd Monoclonal antibodies specific to glactosyltransferase isoenzyme II and their use in cancer immunoassays
US5426029A (en) * 1986-03-31 1995-06-20 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using leukocyte surface antigens
US5217869A (en) * 1987-10-13 1993-06-08 Terrapin Technologies, Inc. Method to produce immunodiagnostic reagents
GB8810400D0 (en) * 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5059522A (en) * 1988-08-18 1991-10-22 Wayne Lawrence G Intrinsic enzyme dot blot immunoassay or indentification of microorganisms
US6040138A (en) * 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5532135A (en) * 1990-02-02 1996-07-02 Cancer Research Fund Of Contra Costa Solid-phase competitive assay utilizing a fusion protein
US5726064A (en) * 1990-11-22 1998-03-10 Applied Research Systems Ars Holding Nv Method of assay having calibration within the assay
US5234816A (en) * 1991-07-12 1993-08-10 Becton, Dickinson And Company Method for the classification and monitoring of leukemias
US5597735A (en) * 1992-05-11 1997-01-28 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Health And Welfare Glycolipids for serodiagnosis of tuberculosis and leprosy
CA2142860A1 (en) * 1992-08-21 1994-03-03 Gregorio Aversa Human interleukin-13
ES2051651B1 (es) * 1992-12-10 1995-01-01 Univ Salamanca Procedimiento para la cuantificacion simultanea, en una sola medicion, de los principales tipos de linfocitos humanos y sus subpoblaciones.
EP0610774B1 (de) * 1993-02-09 2001-03-28 Becton, Dickinson and Company Automatische Bestimmung der Zellinie schwerer Leukämien durch Flusszytometrie
AU7556994A (en) * 1993-08-13 1995-03-14 Molecular Geriatrics Corporation Methods for the diagnosis of alzheimer's disease
US5692220A (en) * 1993-09-02 1997-11-25 Coulter Corporation Decision support system and method for diagnosis consultation in laboratory hematopathology
WO1995009912A1 (en) * 1993-10-06 1995-04-13 University Of Florida Research Foundation, Inc. Stem cell proliferation factor
US5861158A (en) * 1993-11-17 1999-01-19 The United States Of America As Represented By The Deptartment Of Health And Human Services Method and composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor
JP3533541B2 (ja) * 1995-01-25 2004-05-31 旭メディカル株式会社 細胞選択フィルター
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
US6265150B1 (en) * 1995-06-07 2001-07-24 Becton Dickinson & Company Phage antibodies
US5968513A (en) 1996-06-24 1999-10-19 University Of Maryland Biotechnology Institute Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin
WO1998008083A1 (en) * 1996-08-20 1998-02-26 Motorola Inc. Method and apparatus for detecting predetermined molecular structures in a sample
US6087102A (en) 1998-01-07 2000-07-11 Clontech Laboratories, Inc. Polymeric arrays and methods for their use in binding assays
CA2318175A1 (en) 1998-02-04 1999-08-12 Invitrogen Corporation Microarrays and uses therefor

Also Published As

Publication number Publication date
EP1151300A4 (de) 2002-07-31
CN1231761C (zh) 2005-12-14
US7560226B2 (en) 2009-07-14
HK1041922A1 (en) 2002-07-26
DK1151300T3 (da) 2010-07-12
PT1151300E (pt) 2010-06-21
JP2002533723A (ja) 2002-10-08
BR9916449A (pt) 2002-01-22
ATE466280T1 (de) 2010-05-15
US20020019018A1 (en) 2002-02-14
NZ525421A (en) 2004-10-29
EP1151300B1 (de) 2010-04-28
CA2356286C (en) 2010-12-21
KR100795757B1 (ko) 2008-01-21
ES2344180T3 (es) 2010-08-19
CA2356286A1 (en) 2000-07-06
WO2000039580A1 (en) 2000-07-06
KR20010093221A (ko) 2001-10-27
JP4763135B2 (ja) 2011-08-31
CN1334922A (zh) 2002-02-06
EP1151300A1 (de) 2001-11-07

Similar Documents

Publication Publication Date Title
DE69942314D1 (de) Versuchsanordnung zum nachweis von bindungspartnern
TR200000565T2 (tr) Biyolojik örneklerdeki analiz bileşenlerinin hızlı analizi için yöntem
ATE254285T1 (de) Geräte und verfahren, die strukturfelder zum binden von analyten verwenden
DE69530861D1 (de) Vorrichtung zur durchführung eines oder mehrerer kompetitiver immunoassays
ATE290205T1 (de) Vorrichtung und verfahren zum nachweis und identifizieren von infektiösen wirkstoffen
ES2187622T3 (es) Reactivos y dispositivos de ensayo.
DE69623458T2 (de) Einstufige immunochromatographische vorrichtung und verfahren zu ihrer verwendung
DE59814441D1 (de) Verwendung von kontrollflächen zur detektion von störproben in einem nachweisverfahren
TR200001313T2 (tr) Protein etkileşimlerini ve fonksiyonel ilişkileri kaydeden tarama sistemleri
DE69928507D1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
NO20083610L (no) Cobalamin-maling
ATE285581T1 (de) Assay-verfahren
DE68919387D1 (de) DNS- und RNS-Proben, Methoden und Testsätze zum Nachweis von Salmonella.
DE69617568T2 (de) Immunoassay Vorrichtung und Testverfahren zu seiner Verwendung
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
DK0672252T3 (da) Immunoassay
ATE312203T1 (de) Dynamische bestimmung von analyten durch arrays auf inneren oberflächen
ES2004066A6 (es) Metodo para analisis cualitativo y-o cuantitativo de antigenos,anticuerpos yno microorganismos u otras celulas y su correspondiente equipo
DK0998974T3 (da) Fremgangsmåde til målrettet anbringelse af reagenser på immobiliseret biologisk materiale

Legal Events

Date Code Title Description
8364 No opposition during term of opposition